A study by Goethe University Frankfurt points to the possibility that thalidomide derivatives are potentially suitable for treating cancer. Thalidomide was marketed in the 1950s as a sleeping pill. It ...
Syntekabio, an artificial intelligence (AI) new drug development specialist company (CEO Jeong Jong-seon), announced on the 22nd that it has completed the registration of a patent for the "Method for ...
A study points to the possibility that thalidomide derivatives are potentially suitable for treating cancer. Thalidomide was marketed in the 1950s as a sleeping pill. It later gained sad notoriety for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results